E-LIB Suche - Ergebnisse für: Taft, David R

1

Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibit..:

Moon, Chaeho ; Sahakijpijarn, Sawittree ; Maier, Esther Y....
Molecular Pharmaceutics. 21 (2024) 2 - p. 564-580 , 2024

2

Correction to "Inhaled JAK Inhibitor GDC-0214 Nanoaggregate..:

Moon, Chaeho ; Sahakijpijarn, Sawittree ; Maier, Esther Y....
Molecular Pharmaceutics. 21 (2024) 6 - p. 3077-3077 , 2024

Link: https://doi.org/10.1021/..

3

PBPK Modeling of Azithromycin Systemic Exposure in a Roux-e..:

Avvari, Suvarchala Kiranmai ; Cusumano, Jaclyn A. ; Jogiraju, Vamshi Krishna..
Pharmaceutics. 15 (2023) 11 - p. 2520 , 2023

Link: https://doi.org/10.3390/..

4

Developing a Formulation Strategy Coupled with PBPK Modelin..:

Shah, Harsh ; Shah, Kushal ; Gajera, Bhavin..
Pharmaceutics. 15 (2023) 4 - p. 1040 , 2023

Link: https://doi.org/10.3390/..

5

Application of Physiologically Based Pharmacokinetic‐Pharma..:

Neeli, Harshith ; Hanna, Nazeeh ; Abduljalil, Khaled..
The Journal of Clinical Pharmacology. 61 (2021) 10 - p. 1356-1365 , 2021

Link: https://doi.org/10.1002/..

6

Physiologically based pharmacokinetic modeling of altered t..:

Jogiraju, Vamshi Krishna ; Heimbach, Tycho ; Toderika, Yuliana.
Drug Metabolism and Pharmacokinetics. 37 (2021) - p. 100375 , 2021

Link: https://doi.org/10.1016/..

7

Effect of Gender on the Pharmacokinetics of ON 123300, A Du..:

Mudunuru, Jennypher ; Ren, Chen ; Taft, David R..
European Journal of Drug Metabolism and Pharmacokinetics. 44 (2019) 4 - p. 531-538 , 2019

Link: https://doi.org/10.1007/..

8

Real-World Experience With Higher-Than-Recommended Doses of..:

Fischetti, Briann ; Shah, Kushal ; Taft, David R...
Open Forum Infectious Diseases. 5 (2018) 10 - p. , 2018

Link: https://doi.org/10.1093/..

9

Application of physiologically based pharmacokinetic modeli..:

Jogiraju, Vamshi Krishna ; Avvari, Suvarchala ; Gollen, Rakesh.
Biopharmaceutics & Drug Disposition. 38 (2017) 7 - p. 426-438 , 2017

Link: https://doi.org/10.1002/..

10

Gentamicin Renal Excretion in Rats: Probing Strategies to M..:

Dontabhaktuni, Aruna ; Taft, David R. ; Patel, Mayankbhai
Pharmacology & Pharmacy. 7 (2016) 1 - p. 43-55 , 2016

Link: https://doi.org/10.4236/..

11

Evaluating the Potential for Delivery of Irinotecan via the..:

Shah, Vidhi ; Bellantone, Robert A. ; Taft, David R.
AAPS PharmSciTech. 18 (2016) 3 - p. 867-874 , 2016

Link: https://doi.org/10.1208/..

12

Disposition of ON 01210.Na (Ex-RAD(R)), a Novel Radioprotec..:

Tamhane, Mitalee ; Maniar, Manoj ; Ren, Chen..
Journal of Pharmaceutical Sciences. 102 (2013) 2 - p. 732-740 , 2013

Link: https://doi.org/10.1002/..

13

Determination of intestinal permeability of rigosertib (ON ..:

White, Michael P ; Babayeva, Mariana ; Taft, David R.
Journal of Pharmacy and Pharmacology. 65 (2013) 7 - p. 960-969 , 2013

Link: https://doi.org/10.1111/..

14

Radioprotective Effects of ON 01210.Na upon Oral Administra..:

SUMAN, Shubhankar ; DATTA, Kamal ; DOIRON, Kathryn...
Journal of Radiation Research. 53 (2012) 3 - p. 368-376 , 2012

Link: https://doi.org/10.1269/..

15

Renal excretion of apricitabine in rats: ex vivo and in viv..:

Babayeva, Mariana ; Cox, Susan ; White, Michael P..
European Journal of Drug Metabolism and Pharmacokinetics. 36 (2011) 3 - p. 141-150 , 2011

Link: https://doi.org/10.1007/..